David S. Grayzel's Net Worth
$0
Who is David S. Grayzel?
David S. Grayzel does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Aerovate Therapeutics, Inc., Surface Oncology, Inc., and Q32 Bio Inc..
SEC CIK
David S. Grayzel's CIK is 0001732786
Past Insider Trading and Trends
2024 was David S. Grayzel's most active year for acquiring shares with 4 total transactions. David S. Grayzel's most active month to acquire stocks was the month of May. 2022 saw David S. Grayzel paying a total of $47,999.52 for 43,817 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $1.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| -45.03% | -11.88K |
$28.15 | -$334,478.30 | 14.5K |
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 3.1M |
$14.00 |
—
| 3.1M |
Jul 1 - Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1 - Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surface Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.95M |
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4/A
| -36.59% | -1.70M |
$8.10 | -$13,770,000.00 | 2.95M |
Dec 17
| |||
Form 4
| -36.59% | -1.70M |
$18.10 | -$30,770,000.00 | 2.95M |
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +240.67% | 3.28M |
$15.00 |
—
| 4.65M |
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Q32 Bio Inc. (QTTB) Snapshot price: $45.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||